TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
QIAGEN DNA Synthesis AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
67,221
|
52,430
|
62,204 |
Financial expenses |
6,005
|
3,315
|
1,770 |
Earnings before taxes |
-26,604
|
-35,550
|
-23,631 |
EBITDA |
-13,309
|
-26,878
|
-16,582 |
Total assets |
113,219
|
106,603
|
103,549 |
Current assets |
58,135
|
60,039
|
53,850 |
Current liabilities |
88,458
|
93,924
|
94,697 |
Equity capital |
24,761
|
12,679
|
8,852 |
- share capital |
134
![]() |
134
|
145 |
Employees (average) |
99
|
105
|
97 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
21.9%
|
11.9%
|
8.5% |
Turnover per employee |
679
|
499
|
641 |
Profit as a percentage of turnover |
-39.6%
|
-67.8%
|
-38.0% |
Return on assets (ROA) |
-18.2%
|
-30.2%
|
-21.1% |
Current ratio |
65.7%
|
63.9%
|
56.9% |
Return on equity (ROE) |
-107.4%
|
-280.4%
|
-267.0% |
Change turnover |
14,522
|
-4,736
|
-32,466 |
Change turnover % |
28%
|
-8%
|
-34% |
Chg. No. of employees |
-6
|
8
|
6 |
Chg. No. of employees % |
-6%
|
8%
|
7% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.